Corvus Pharmaceuticals (CRVS) Revenue (2015 - 2026)
Corvus Pharmaceuticals (CRVS) revenue from Mar 31, 2015 to Mar 31, 2026. The TTM Corvus Pharmaceuticals (CRVS) revenue is $3.76M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Corvus Pharmaceuticals (CRVS) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +84.31% |
| 3 Years TTM | +79.51% |
Annual Revenue change of Corvus Pharmaceuticals (CRVS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $1.78M | -29.08% |
| 2025 | $2.51M | +37.91% |
| 2024 | $1.82M | +15.19% |
| 2023 | $1.58M | +143.08% |
| 2022 | $650K | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |